Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2014 | 12-2013 | 06-2013 | 12-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,680 | N/A | -9,600 | N/A | -5,470 |
| Depreciation Amortization | 0 | N/A | 400 | N/A | 580 |
| Other Working Capital | 0 | N/A | 670 | N/A | 80 |
| Other Operating Activity | -13,760 | 0 | 810 | 0 | -3,110 |
| Operating Cash Flow | $-10,080 | $N/A | $-7,720 | $N/A | $-7,920 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40 | N/A | -50 | N/A | -40 |
| Other Investing Activity | 250 | 0 | -130 | 0 | 540 |
| Investing Cash Flow | $210 | $N/A | $-180 | $N/A | $500 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 10,940 | 0 | 440 | 0 | 11,200 |
| Financing Cash Flow | $10,940 | $N/A | $440 | $N/A | $11,200 |
| Exchange Rate Effect | -50 | N/A | 80 | N/A | 130 |
| Beginning Cash Position | 1,580 | N/A | 9,140 | N/A | 5,270 |
| End Cash Position | 2,600 | N/A | 1,760 | N/A | 9,190 |
| Net Cash Flow | $1,010 | $N/A | $-7,370 | $N/A | $3,920 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,080 | N/A | -7,720 | N/A | -7,920 |
| Free Cash Flow | -10,080 | 0 | -7,720 | 0 | -7,920 |